A comparison of fibrosis progression in chronic liver diseases-Reference-Cited by-同舟云学术

A comparison of fibrosis progression in chronic liver diseases

Published:2003-03 Issue:3 Volume:38 Page:257-265
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Poynard Thierry,Mathurin Philippe,Lai Ching-Lung,Guyader Dominique,Poupon Renée,Tainturier Marie-Hélène,Myers Robert P.,Muntenau Mona,Ratziu Vlad,Manns Michael,Vogel Arndt,Capron Frédérique,Chedid Antonio,Bedossa Pierre

Publisher

Elsevier BV

Subject

Hepatology

Reference38 articles.

1. The cellular basis of hepatic fibrosis: mechanisms and treatment strategies;Friedman;N Engl J Med,1993

2. Clinical outcomes after transfusion-associated hepatitis C;Tong;N Engl J Med,1995

3. Natural history of liver fibrosis progression in patients with chronic hepatitis C;Poynard;Lancet,1997

4. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study;Liaw;Hepatology,1988

5. Trends of liver cirrhosis mortality in Europe, 1970–1989: age–period–cohort analysis and changing alcohol consumption;Corrao;Int J Epidemiol,1997

Cited by 383 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apoptotic vesicles (apoVs) derived from fibroblast-converted hepatocyte-like cells effectively ameliorate liver fibrosis;Journal of Nanobiotechnology;2024-09-05

2. Serum zinc level in liver cirrhosis with hepatic encephalopathy and its correlation with different stages of hepatic encephalopathy;Journal of Family Medicine and Primary Care;2024-09

3. Advancements of non‐invasive imaging technologies for the diagnosis and staging of liver fibrosis: Present and future;VIEW;2024-07-15

4. Molecular targets of PXR-dependent ethanol-induced hepatotoxicity in female mice;Biochemical Pharmacology;2024-07

5. Key points for the management of hepatitis C in the era of pan-genotypic direct-acting antiviral therapy;Exploration of Digestive Diseases;2024-06-18